238 related articles for article (PubMed ID: 33073486)
1. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values and immune suppression of the S100A family in pancreatic cancer.
Zhuang H; Chen X; Dong F; Zhang Z; Zhou Z; Ma Z; Huang S; Chen B; Zhang C; Hou B
J Cell Mol Med; 2021 Mar; 25(6):3006-3018. PubMed ID: 33580614
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.
Zhu T; Chen R; Wang J; Yue H; Lu X; Li J
Cancer Cell Int; 2020; 20():257. PubMed ID: 32565741
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.
Xie H; Qin C; Zhou X; Liu J; Yang K; Nong J; Luo J; Peng T
Medicine (Baltimore); 2023 Aug; 102(33):e34765. PubMed ID: 37603520
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
6. GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8+ T cells infiltration in pancreatic cancer.
Zhuang H; Zhang C; Hou B
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936232
[TBL] [Abstract][Full Text] [Related]
7. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
[TBL] [Abstract][Full Text] [Related]
9. B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8
Zhuang H; Zhou Z; Zhang Z; Chen X; Ma Z; Huang S; Gong Y; Zhang C; Hou B
Aging (Albany NY); 2020 Dec; 13(2):2310-2329. PubMed ID: 33316775
[TBL] [Abstract][Full Text] [Related]
10. Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.
Nurzat Y; Su W; Min P; Li K; Xu H; Zhang Y
Front Oncol; 2021; 11():751875. PubMed ID: 34660316
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
Yu J; Yang K; Zheng J; Sun X; Zhao W
Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
[TBL] [Abstract][Full Text] [Related]
12. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract][Full Text] [Related]
13. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
14. ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancer.
Gu W; Sun H; Zhang M; Mo S; Tan C; Ni S; Yang Z; Wang Y; Sheng W; Wang L
Cancer Med; 2023 Jan; 12(2):1520-1531. PubMed ID: 35864742
[TBL] [Abstract][Full Text] [Related]
15. Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family-related genes.
Wu Y; Fu L; Wang B; Li Z; Wei D; Wang H; Zhang C; Ma Z; Zhu T; Yu G
J Clin Lab Anal; 2022 Jun; 36(6):e24419. PubMed ID: 35403268
[TBL] [Abstract][Full Text] [Related]
16. Identification of Circ_001569 as a Potential Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer.
Shen X; Chen Y; Li J; Huang H; Liu C; Zhou N
Technol Cancer Res Treat; 2021; 20():1533033820983302. PubMed ID: 33413045
[TBL] [Abstract][Full Text] [Related]
17. The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation.
Yang R; Liang X; Wang H; Guo M; Shen H; Shi Y; Liu Q; Sun Y; Yang L; Zhan M
EBioMedicine; 2021 Jan; 63():103195. PubMed ID: 33418496
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
19. FAM83H overexpression predicts worse prognosis and correlates with less CD8
Zhuang H; Zhang C; Hou B
Clin Transl Oncol; 2020 Dec; 22(12):2244-2252. PubMed ID: 32424701
[TBL] [Abstract][Full Text] [Related]
20. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.
Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW
Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
